Mannkind (MNKD) Other Non-Current Liabilities (2012 - 2026)
Mannkind (MNKD) reported Other Non-Current Liabilities of $5.1 million for Q1 2026, up 0.63% quarter-over-quarter from $5.1 million in Q4 2025.
Mannkind (MNKD) Other Non-Current Liabilities (2012 - 2026) Analysis & Trends
Mannkind (MNKD) has 15 years of Other Non-Current Liabilities data on file, last reported at $5.1 million in Q1 2026.
- Other Non-Current Liabilities for Q1 2026 came in at $5.1 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $5.1 million (changed N/A YoY), and the FY2025 annual result was $5.1 million, changed N/A from the prior year.
- Other Non-Current Liabilities advanced to $5.1 million in Q1 2026 per MNKD's latest filing, from $5.1 million in the prior quarter.
- Over five years, Other Non-Current Liabilities peaked at $7.1 million in Q1 2022 and troughed at $54000.0 in Q1 2023.
- A 5-year average of $1.6 million and a median of $56000.0 in 2022 frame the typical range for Other Non-Current Liabilities.
- The sharpest annual moves came in 2022 and 2023: Other Non-Current Liabilities soared 48.41% in 2022, then tumbled 99.23% in 2023.
- A 5-year view of Other Non-Current Liabilities shows it stood at $55000.0 in 2022, then grew by 1.82% to $56000.0 in 2023, then slipped by 1.79% to $55000.0 in 2024, then jumped by 9198.18% to $5.1 million in 2025, then gained by 0.63% to $5.1 million in 2026.
- Business Quant data shows MNKD's Other Non-Current Liabilities at $5.1 million in Q1 2026, $5.1 million in Q4 2025, and $55000.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.15 Mn |
| Dec 31, 2025 | 5.11 Mn |
| Mar 31, 2024 | 55,000.00 |
| Dec 31, 2023 | 56,000.00 |
| Sep 30, 2023 | 57,000.00 |
| Jun 30, 2023 | 55,000.00 |
| Mar 31, 2023 | 54,000.00 |
| Dec 31, 2022 | 55,000.00 |
| Sep 30, 2022 | 56,000.00 |
| Jun 30, 2022 | 86,000.00 |
| Mar 31, 2022 | 7.05 Mn |
| Dec 31, 2021 | 4.95 Mn |
| Sep 30, 2021 | 286,000.00 |
| Jun 30, 2021 | 169,000.00 |
| Mar 31, 2021 | 4.75 Mn |
| Dec 31, 2020 | 4.15 Mn |
| Sep 30, 2020 | 5.85 Mn |
| Jun 30, 2020 | 4.54 Mn |
| Mar 31, 2020 | 3.26 Mn |
| Dec 31, 2019 | 2.00 Mn |